成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

TargetMolไธญๅœ‹๏ผˆ้™ถ่ก“็”Ÿ็‰ฉ๏ผ‰ ๅ…ฌๅธไฟกๆฏ

ๅ…ฌๅธๅ็จฑ: TargetMolไธญๅœ‹๏ผˆ้™ถ่ก“็”Ÿ็‰ฉ๏ผ‰
้›ป่ฉฑ: -
้›ปๅญ้ƒตไปถ:marketing@targetmol.com
ๅœ‹็ฑ:ไธญๅœ‹
็ถฒๅ€: https://www.targetmol.cn/
็”ขๅ“็ธฝๆ•ธ:19704

ๅ…ฌๅธๆไพ›็”ขๅ“ๅˆ—่กจ

VEGFR-2-IN-22 ๅŒ–ๅˆ็‰ฉ VEGFR-2-IN-22 2447587-73-5
Lipid-lowering agent-1 ๅŒ–ๅˆ็‰ฉ Lipid-lowering agent-1 2304859-34-3
AChE-IN-20 ๅŒ–ๅˆ็‰ฉ AChE-IN-20 2428389-65-3
Antibacterial agent 115 ๅŒ–ๅˆ็‰ฉ Antibacterial agent 115 2259732-60-8
Axl-IN-8 ๅŒ–ๅˆ็‰ฉ Axl-IN-8 2231424-62-5
MAT2A-IN-1 ๅŒ–ๅˆ็‰ฉ MAT2A-IN-1 2667053-18-9
DPP-4/GPR119 modulator 2 ๅŒ–ๅˆ็‰ฉ DPP-4/GPR119 modulator 2 2010927-65-6
LRRK2-IN-2 ๅŒ–ๅˆ็‰ฉ LRRK2-IN-2 2641059-19-8
Axl-IN-12 ๅŒ–ๅˆ็‰ฉ Axl-IN-12 2758062-17-6
ERฮฑ antagonist 1 ๅŒ–ๅˆ็‰ฉ ERฮฑ antagonist 1 2762423-09-4
PAK4-IN-1 ๅŒ–ๅˆ็‰ฉ PAK4-IN-1 2396529-58-9
VEGFR-2-IN-28 ๅŒ–ๅˆ็‰ฉ VEGFR-2-IN-28 2447597-39-7
Cap-dependent endonuclease-IN-5 ๅŒ–ๅˆ็‰ฉ Cap-dependent endonuclease-IN-5 2416258-53-0
CDK9/10/GSK3ฮฒ-IN-1 ๅŒ–ๅˆ็‰ฉ CDK9/10/GSK3ฮฒ-IN-1 2423045-06-9
RET-IN-19 ๅŒ–ๅˆ็‰ฉ RET-IN-19 2484919-71-1
EZH2-IN-11 ๅŒ–ๅˆ็‰ฉ EZH2-IN-11 2387402-80-2
DHODH-IN-22 ๅŒ–ๅˆ็‰ฉ DHODH-IN-22 2450341-75-8
BLK-IN-1 ๅŒ–ๅˆ็‰ฉ BLK-IN-1 1431727-00-2
EGFR-IN-50 ๅŒ–ๅˆ็‰ฉ EGFR-IN-50 2044508-48-5
ATR-IN-5 ๅŒ–ๅˆ็‰ฉ ATR-IN-5 2601571-19-9
KS100 ๅŒ–ๅˆ็‰ฉ KS100 2408477-54-1
Omesdafexor ๅŒ–ๅˆ็‰ฉ Omesdafexor 2244440-85-3
XP-524 ๅŒ–ๅˆ็‰ฉ XP-524 2344825-52-9
GLP-1R agonist 10 ๅŒ–ๅˆ็‰ฉ GLP-1R agonist 10 2762515-25-1
HER2-IN-8 ๅŒ–ๅˆ็‰ฉ HER2-IN-8 2704630-49-7
HDAC-IN-44 ๅŒ–ๅˆ็‰ฉ HDAC-IN-44 2414921-46-1
Anticancer agent 76 ๅŒ–ๅˆ็‰ฉ Anticancer agent 76 2448091-11-8
MMP-9-IN-4 ๅŒ–ๅˆ็‰ฉ MMP-9-IN-4 2581824-39-5
HIV-IN-5 ๅŒ–ๅˆ็‰ฉ HIV-IN-5 2459929-62-3
Antitubercular agent-20 ๅŒ–ๅˆ็‰ฉ Antitubercular agent-20 2413124-92-0
c-Met-IN-13 ๅŒ–ๅˆ็‰ฉ c-Met-IN-13 2377724-93-9
HER2-IN-7 ๅŒ–ๅˆ็‰ฉ HER2-IN-7 2387574-01-6
Antitumor agent-45 ๅŒ–ๅˆ็‰ฉ Antitumor agent-45 2581082-74-6
Keap1-Nrf2-IN-14 ๅŒ–ๅˆ็‰ฉ Keap1-Nrf2-IN-14 1928782-31-3
RAD51-IN-5 ๅŒ–ๅˆ็‰ฉ RAD51-IN-5 2690367-19-0
mGAT-IN-1 ๅŒ–ๅˆ็‰ฉ mGAT-IN-1 2556833-08-8
BACE1-IN-12 ๅŒ–ๅˆ็‰ฉ BACE1-IN-12 2479315-19-8
IKKฮฒ-IN-1 ๅŒ–ๅˆ็‰ฉ IKKฮฒ-IN-1 2410423-31-1
Tubulin polymerization-IN-7 ๅŒ–ๅˆ็‰ฉ Tubulin polymerization-IN-7 1394017-46-9
IRE1ฮฑ kinase-IN-3 ๅŒ–ๅˆ็‰ฉ IRE1ฮฑ kinase-IN-3 2416223-41-9
Anticancer agent 50 ๅŒ–ๅˆ็‰ฉ Anticancer agent 50 2487457-15-6
CCT373567 ๅŒ–ๅˆ็‰ฉ CCT373567 2378853-67-7
CYP3A4-IN-1 ๅŒ–ๅˆ็‰ฉ CYP3A4-IN-1 2771297-34-6
Adenylyl cyclase type 2 agonist-1 ๅŒ–ๅˆ็‰ฉ Adenylyl cyclase type 2 agonist-1 2414908-52-2
BCR-ABL-IN-4 ๅŒ–ๅˆ็‰ฉ BCR-ABL-IN-4 2669790-59-2
HIV-1 protease-IN-2 ๅŒ–ๅˆ็‰ฉ HIV-1 protease-IN-2 2248124-46-9
hCAXII-IN-3 ๅŒ–ๅˆ็‰ฉ hCAXII-IN-3 2417232-24-5
PDE5/HDAC-IN-1 ๅŒ–ๅˆ็‰ฉ PDE5/HDAC-IN-1 2414921-48-3
DNMT3A-IN-1 ๅŒ–ๅˆ็‰ฉ DNMT3A-IN-1 1403598-56-0
PI3K-IN-27 ๅŒ–ๅˆ็‰ฉ PI3K-IN-27 2742654-38-0
DCN1-UBC12-IN-2 ๅŒ–ๅˆ็‰ฉ DCN1-UBC12-IN-2 2374827-47-9
LXRฮฒ agonist-3 ๅŒ–ๅˆ็‰ฉ LXRฮฒ agonist-3 2413308-63-9
IZTZ-1 ๅŒ–ๅˆ็‰ฉ IZTZ-1 2636771-45-2
Thi-DPPY ๅŒ–ๅˆ็‰ฉ Thi-DPPY 2307699-34-7
AChE-IN-12 ๅŒ–ๅˆ็‰ฉ AChE-IN-12 2764664-52-8
Anti-Trypanosoma cruzi agent-3 ๅŒ–ๅˆ็‰ฉ Anti-Trypanosoma cruzi agent-3 2397639-23-3
Kallikrein-IN-2 ๅŒ–ๅˆ็‰ฉ Kallikrein-IN-2 2702983-84-2
Multi-kinase-IN-2 ๅŒ–ๅˆ็‰ฉ Multi-kinase-IN-2 2095628-21-8
Antitubercular agent-19 ๅŒ–ๅˆ็‰ฉ Antitubercular agent-19 2248171-05-1
hGGPPS-IN-2 ๅŒ–ๅˆ็‰ฉ hGGPPS-IN-2 2241547-82-8
Lp-PLA2-IN-9 ๅŒ–ๅˆ็‰ฉ Lp-PLA2-IN-9 2637485-12-0
EGFR-IN-32 ๅŒ–ๅˆ็‰ฉ EGFR-IN-32 2701553-78-6
Anticancer agent 41 ๅŒ–ๅˆ็‰ฉ Anticancer agent 41 1394077-28-1
A3AR antagonist 1 ๅŒ–ๅˆ็‰ฉ A3AR antagonist 1 2413257-74-4
HDAC-IN-36 ๅŒ–ๅˆ็‰ฉ HDAC-IN-36 2482992-54-9
Cap-dependent endonuclease-IN-17 ๅŒ–ๅˆ็‰ฉ Cap-dependent endonuclease-IN-17 2649362-71-8
Antimycobacterial agent-3 ๅŒ–ๅˆ็‰ฉ Antimycobacterial agent-3 2469881-50-1
PRMT5-IN-18 ๅŒ–ๅˆ็‰ฉ PRMT5-IN-18 2756849-68-8
Axl-IN-5 ๅŒ–ๅˆ็‰ฉ Axl-IN-5 2642224-24-4
ฮฑ-Glycosidase-IN-1 ๅŒ–ๅˆ็‰ฉ ฮฑ-Glycosidase-IN-1 2428389-66-4
CYP3A4-IN-2 ๅŒ–ๅˆ็‰ฉ CYP3A4-IN-2 2562383-94-0
ACC1/2-IN-1 ๅŒ–ๅˆ็‰ฉ ACC1/2-IN-1 2350219-22-4
Anticancer agent 67 ๅŒ–ๅˆ็‰ฉ Anticancer agent 67 2691895-66-4
CYP3A4-IN-3 ๅŒ–ๅˆ็‰ฉ CYP3A4-IN-3 2562384-19-2
RET-IN-17 ๅŒ–ๅˆ็‰ฉ RET-IN-17 1885880-08-9
Estrogen receptor antagonist 3 ๅŒ–ๅˆ็‰ฉ Estrogen receptor antagonist 3 2730011-50-2
RAD51-IN-6 ๅŒ–ๅˆ็‰ฉ RAD51-IN-6 2690367-57-6
HBV-IN-19 TFA ๅŒ–ๅˆ็‰ฉ HBV-IN-19 TFA 2241575-60-8
EGFR-IN-31 ๅŒ–ๅˆ็‰ฉ EGFR-IN-31 2701563-03-1
GLP-1R agonist 8 ๅŒ–ๅˆ็‰ฉ GLP-1R agonist 8 2736446-82-3
BuChE-IN-2 ๅŒ–ๅˆ็‰ฉ BuChE-IN-2 2745118-93-6
c-Fms-IN-12 ๅŒ–ๅˆ็‰ฉ c-Fms-IN-12 2145102-33-4
RORฮณt inverse agonist 28 ๅŒ–ๅˆ็‰ฉ RORฮณt inverse agonist 28 2741870-21-1
LDC0496 ๅŒ–ๅˆ็‰ฉ LDC0496 2411874-83-2
Multi-kinase-IN-3 ๅŒ–ๅˆ็‰ฉ Multi-kinase-IN-3 2091950-43-3
ALK5-IN-9 ๅŒ–ๅˆ็‰ฉ ALK5-IN-9 2489611-06-3
Cap-dependent endonuclease-IN-14 ๅŒ–ๅˆ็‰ฉ Cap-dependent endonuclease-IN-14 2740486-73-9
HBV-IN-6 ๅŒ–ๅˆ็‰ฉ HBV-IN-6 2724224-47-7
hCA I-IN-2 ๅŒ–ๅˆ็‰ฉ hCA I-IN-2 2417232-12-1
SAP2-IN-1 ๅŒ–ๅˆ็‰ฉ SAP2-IN-1 2512847-37-7
RORฮณt agonist 3 ๅŒ–ๅˆ็‰ฉ RORฮณt agonist 3 2664106-24-3
RECQL5-IN-1 ๅŒ–ๅˆ็‰ฉ RECQL5-IN-1 2718170-45-5
B-Raf IN 6 ๅŒ–ๅˆ็‰ฉ B-Raf IN 6 2648698-34-2
Sitagliptin fenilalanil ๅŒ–ๅˆ็‰ฉ Sitagliptin fenilalanil 1339955-03-1
PLK1-IN-4 ๅŒ–ๅˆ็‰ฉ PLK1-IN-4 2622273-55-4
Anticancer agent 61 ๅŒ–ๅˆ็‰ฉ Anticancer agent 61 2413148-53-3
PG 34 ๅŒ–ๅˆ็‰ฉ PG 34 1681056-62-1
WNY1613 ๅŒ–ๅˆ็‰ฉ WNY1613 2650546-39-5
SARS-CoV-2-IN-19 ๅŒ–ๅˆ็‰ฉ SARS-CoV-2-IN-19 2244991-17-9
HBV-IN-8 ๅŒ–ๅˆ็‰ฉ HBV-IN-8 2724224-57-9
Copyright 2007? ChemicalBook. All rights reserved.